Target
Dual specificity protein kinase TTK
Ligand
BDBM50569976
Substrate
n/a
Meas. Tech.
ChEMBL_2110865 (CHEMBL4819715)
Kd
0.500000±n/a nM
Citation
 Huang, MHuang, YGuo, JYu, LChang, YWang, XLuo, JHuang, YTu, ZLu, XXu, YZhang, ZZhang, ZDing, K Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors. Eur J Med Chem 211:0 (2021) [PubMed]  Article 
Target
Name:
Dual specificity protein kinase TTK
Synonyms:
Dual specificity protein kinase (TTK) | Dual specificity protein kinase TTK (MPS1) | MPS1 | MPS1L1 | Monopolar Spindle 1 (MPS1) | Monopolar Spindle 1 (Mps-1) | Monopolar Spindle 1 Kinase (MPS1) | Phosphotyrosine picked threonine-protein kinase (MPS1) | TTK | TTK_HUMAN
Type:
Protein
Mol. Mass.:
97086.79
Organism:
Homo sapiens (Human)
Description:
P33981
Residue:
857
Sequence:
MESEDLSGRELTIDSIMNKVRDIKNKFKNEDLTDELSLNKISADTTDNSGTVNQIMMMANNPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLTAQESFSGSLGHLQNRNNSCDSRGQTTKARFLYGENMPPQDAEIGYRNSLRQTNKTKQSCPFGRVPVNLLNSPDCDVKTDDSVVPCFMKRQTSRSECRDLVVPGSKPSGNDSCELRNLKSVQNSHFKEPLVSDEKSSELIITDSITLKNKTESSLLAKLEETKEYQEPEVPESNQKQWQSKRKSECINQNPAASSNHWQIPELARKVNTEQKHTTFEQPVFSVSKQSPPISTSKWFDPKSICKTPSSNTLDDYMSCFRTPVVKNDFPPACQLSTPYGQPACFQQQQHQILATPLQNLQVLASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK
  
Inhibitor
Name:
BDBM50569976
Synonyms:
CHEMBL4867504
Type:
Small organic molecule
Emp. Form.:
C30H41N7O3
Mol. Mass.:
547.6916
SMILES:
COc1cc(ccc1Nc1ncc2c(C)cc(=O)n([C@@H]3CC[C@@H](CC3)NC(=O)C(C)C)c2n1)N1CCN(C)CC1 |r,wU:19.19,22.26,(17.49,-16.86,;18.83,-16.09,;18.83,-14.55,;17.5,-13.78,;17.5,-12.24,;18.84,-11.47,;20.17,-12.25,;20.17,-13.79,;21.5,-14.55,;22.83,-13.79,;22.84,-12.25,;24.18,-11.49,;25.5,-12.26,;26.84,-11.49,;26.85,-9.95,;28.17,-12.27,;28.17,-13.81,;29.5,-14.58,;26.83,-14.57,;26.83,-16.11,;25.49,-16.88,;25.48,-18.42,;26.82,-19.19,;28.16,-18.43,;28.16,-16.89,;26.82,-20.73,;28.14,-21.51,;28.14,-23.05,;29.48,-20.74,;29.49,-19.2,;30.81,-21.52,;25.5,-13.8,;24.16,-14.57,;16.17,-11.46,;14.84,-12.23,;13.5,-11.46,;13.51,-9.92,;12.18,-9.14,;14.84,-9.15,;16.17,-9.92,)|
Structure:
Search PDB for entries with ligand similarity: